Crystal's Coder Hub👃 CPT 30160 — Rhinectomy; Total
Quick Reference
wRVU: 12.06 | Global Period: 090 (90 days) | Assistant Payable: ✅ Yes | Bilateral Indicator: 0
📋 Clinical Description
CPT 30160 describes the total surgical removal of the external nose — including the complete nasal skin envelope, all cartilaginous framework (upper lateral cartilages, lower lateral/alar cartilages, nasal septum to the tip), the bony nasal pyramid (bilateral nasal bones), columella, and all underlying soft tissue to achieve tumor-free margins. This is one of the most extensive procedures performed in head and neck oncologic surgery. The critical distinction from 30150 (partial rhinectomy) is the completeness of the resection — 30160 requires removal of the entire external nasal structure, not a limited excision of one anatomic subunit. When the resection is partial (e.g., removal of one nasal ala, nasal tip only, or the bony dorsum only with preservation of the remaining nose), 30150 is the correct code. When total rhinectomy is performed with concurrent orbital exenteration, extensive skull base resection, or radical neck dissection, each of those additional procedures is separately reportable with appropriate modifiers.
Nasal malignancy — most commonly squamous cell carcinoma (SCC), basal cell carcinoma (BCC), or mucosal melanoma — is the primary indication for total rhinectomy. BCC is the most common skin cancer of the nose globally, but total rhinectomy is reserved for the most extensive, centrally located, or recurrent lesions where partial excision cannot achieve adequate margins. Locally advanced tumors may invade the nasal septum, overlying skin, nasal bones, and anterior skull base, necessitating total extirpation to prevent disease persistence. When tumor invasion extends into the nasal cavity mucosa or paranasal sinuses (maxillary, ethmoid), concurrent sinus surgery codes (31200-31294) may be separately reportable — document each distinct anatomic site treated.
This procedure may be performed in the following clinical contexts:
- Locally advanced or centrally located nasal malignancy (BCC or SCC) — The most common indication; tumors occupying multiple nasal subunits (tip, dorsum, bilateral alae, columella) where partial resection cannot achieve adequate margins and where reconstruction will require total nasal replacement.
- Recurrent nasal malignancy after prior surgery or radiation — Prior treatment (Mohs, partial rhinectomy, radiation) has failed; scarred or irradiated tissue planes make partial re-resection inadequate; total rhinectomy provides the only route to clear margins.
- Mucosal melanoma or adenocarcinoma of the nasal cavity with anterior nasal extension — Sinonasal malignancies extending anteriorly to involve the external nose may require total rhinectomy as part of a craniofacial resection approach; coordinate ICD-10-CM coding between the internal (C30.0) and external (C44.3xx) nose codes based on the primary tumor origin.
- Aggressive or neglected nasal tumors in immunocompromised or elderly patients — Delayed presentation of nasal malignancy can result in very large tumors encompassing the entire external nose; total rhinectomy is the only oncologically appropriate resection.
- Nasal reconstruction failure or prosthetic conversion — Rarely, total rhinectomy may be performed as a component of converting a failed nasal reconstruction to a prosthetic approach; document the clinical indication carefully to support medical necessity.
🔬 Anatomical & Procedural Considerations
| Component | Anatomic Structures Removed | Key Coding & Clinical Notes |
|---|---|---|
| Skin Envelope | All nasal skin from nasion to nasal tip, including bilateral alae and columella skin | Skin closure or skin grafting after resection is typically bundled into the global service for 30160; if a complex separate reconstruction (e.g., forehead flap, free flap) is performed at the same session by the same or a second surgeon, it may be separately reportable — document each surgeon’s distinct contribution |
| Cartilaginous Framework | Upper lateral cartilages, lower lateral (alar) cartilages, nasal tip cartilage complex, anterior cartilaginous septum | Complete removal of all cartilaginous support structures defines “total” rhinectomy; if any cartilaginous component is preserved, re-evaluate whether 30150 (partial) is the correct code |
| Bony Pyramid | Bilateral nasal bones; may include the anterior nasal spine of the maxilla | When resection extends to include the ethmoid, frontal sinus floor, or anterior skull base, additional craniofacial or sinus surgery codes must be evaluated — these are NOT bundled into 30160 |
| Soft Tissue | Periosteum, perichondrium, nasal mucosa (external vestibular lining) to achieve adequate margins | Intraoperative frozen section margin assessment is typically included in the global service; if intraoperative pathology consultation is separately billed by the pathologist, that is a pathology claim — not separately billable by the surgeon |
| Reconstruction | Primary closure, split-thickness skin graft, local flap, staged forehead flap, free flap, or prosthetic rehabilitation | Simultaneous reconstruction at the same session may be separately reportable (e.g., free tissue transfer — 15756, 15757) — confirm with NCCI edits and operative documentation; staged reconstruction is reported separately with modifier -58 during the 90-day global |
Clinical Pearl
The most critical documentation element for 30160 vs. 30150 is an explicit operative note statement confirming that the entire external nose was removed — not merely the dominant tumor subunit. Statements such as “total rhinectomy performed removing the nasal tip, bilateral alae, nasal dorsum, both nasal bones, and columella” or equivalent language confirming completeness of resection must appear in the operative note. If the surgeon preserves any portion of the nasal framework (e.g., the nasal dorsum and bones are left intact while only the lower third is resected), 30150 is more appropriate and billing 30160 will not survive audit. Completeness of resection is the single most audited element for this code pair.
✅ Procedure Includes
- Pre-operative oncologic imaging review (CT, MRI, or PET) confirming tumor extent and resection planning
- General anesthesia (separately billable under the anesthesia provider’s claim — 00350 or appropriate head/neck anesthesia code)
- Marking of resection margins and, when applicable, intraoperative frozen section margin assessment
- Complete excision of the entire external nasal unit — skin, cartilage, nasal bones, columella, and soft tissue to achieve tumor-free margins
- Periosteal and perichondrial dissection required to complete the resection
- Hemostasis and wound irrigation
- Primary wound closure, bolster dressing, or preparation of the wound bed for reconstruction or prosthetic rehabilitation
- Intraoperative consultation with pathology for frozen section margin analysis (surgeon-side — pathology bills separately)
- Operative note documentation confirming complete nasal removal, margins obtained, and reconstruction plan
❌ Excludes / Do Not Report Together
| Code | Description | Relationship to 30160 |
|---|---|---|
| 30150 | rhinectomy; partial | Mutually exclusive — 30150 is the partial version; 30160 applies only when the ENTIRE external nose is removed; do not report both for the same procedure; the operative note must clearly document the extent of resection |
| 11646 | Excision, malignant lesion including margins, face/ears/eyelids/nose/lips; >4.0 cm | Do not report an excision code alongside 30160 for the same lesion; 30160 subsumes the excision — the rhinectomy IS the excision; 11646 would be inappropriate for total rhinectomy and would constitute unbundling |
| 30400 | Rhinoplasty, primary; partial | Do not report rhinoplasty codes alongside total rhinectomy at the same operative session; rhinoplasty codes describe reconstructive reshaping of a present nose — not applicable in the same session as total removal |
| 31200 | Ethmoidectomy; intranasal, anterior | Separately reportable if intranasal ethmoidectomy is performed at the same session for sinonasal tumor extension into the ethmoid sinuses; requires distinct documentation of the sinus procedure and modifier -59 or XS if payer bundles the codes |
| 21182 | Reconstruction of orbital rims and floor; frontal and/or sphenoid sinus, and/or naso-orbital complex | Separately reportable if craniofacial skeletal reconstruction is performed concurrently; document each component in the operative note; modifier -51 on the lower-valued code |
| 15756 | Free muscle or musculocutaneous flap with microvascular anastomosis | Separately reportable when free tissue transfer reconstruction is performed at the same session, typically by a second surgeon; use modifier -62 (co-surgeons) when two surgeons work simultaneously — each surgeon bills their own components; document each surgeon’s distinct contribution |
| E/M codes (992xx / 920xx) | Office visit or hospital visit, any level | Separately reportable only when modifier -25 is appended to the E/M code, documenting a significant, separately identifiable E/M service beyond the routine pre-procedure assessment |
Bundling Alert — Global Period is 090 (90 days)
CPT 30160 carries a 90-day global period, meaning all routine post-operative care — including wound checks, dressing changes, suture removal, and post-operative oncologic monitoring visits directly related to the rhinectomy — is bundled into the procedure payment for 90 days. The most common audit finding is separately billing post-operative visits for wound management during the global window. Staged reconstruction (e.g., delayed forehead flap or free flap repair performed weeks after the initial rhinectomy) is reportable separately using modifier -58 (staged/related procedure), which opens a new global period for the reconstructive procedure. If the patient requires an unrelated service within the 90-day window (e.g., management of a new cardiac issue), append modifier -24 to the E/M code and document the unrelated nature explicitly. The split-global modifiers -54, -55, and -56 are particularly relevant here when the oncologic surgeon performs the resection and a separate reconstructive surgeon assumes post-operative management.
🌳 Code Tree — Surgery: Respiratory System — Excision Procedures on the Nose
CPT 30100-30160 Incision and Excision Procedures on the Nose
│
├── 30100 Biopsy, intranasal (Global: 000)
├── 30110 Excision, nasal polyp(s), simple (Global: 010)
├── 30115 Excision, nasal polyp(s), extensive (Global: 090)
├── 30117 Excision or destruction, intranasal lesion; internal approach (Global: 010)
├── 30118 Excision or destruction, intranasal lesion; external approach (Global: 090)
├── 30120 Excision or surgical planing of skin of nose for rhinophyma (Global: 090)
│
├── 30124 Excision dermoid cyst, nose; not involving intracranial contents (Global: 090)
├── 30125 Excision dermoid cyst, nose; with intracranial extension (Global: 090)
│
├── 30130 Excision inferior turbinate, partial or complete, any method (Global: 090)
├── 30140 Submucous resection inferior turbinate, partial or complete, any method (Global: 090)
│
├── 30150 Rhinectomy; partial (Global: 090)
└── ▶▶ 30160 ◀◀ Rhinectomy; total ← YOU ARE HERE (Global: 090)
💰 RVU & Reimbursement Profile
| Component | Value |
|---|---|
| Work RVU (wRVU) | 12.06 (verify against current CMS MPFS for applicable year) |
| Global Period | 090 (90 days) |
| Bilateral Indicator | 0 — Not a bilateral procedure; the external nose is a single midline structure; bilateral indicator 0 means standard bilateral reduction rules do not apply |
| Assistant Surgeon | ✅ Payable — Modifier -80 (or -82 if qualified resident not available); document medical necessity |
| Co-Surgeon | ✅ Applicable — Modifier -62 when two surgeons of different specialties (e.g., oncologic surgeon + reconstructive surgeon) perform distinct, non-overlapping portions of the procedure simultaneously; each surgeon bills their own component with -62 |
| Team Surgery | ❌ Not applicable for standard total rhinectomy |
| PC/TC Split | ❌ No — Procedure code only (Indicator 0) |
| Modifier -51 Exempt | No — Subject to multiple procedure reduction rules when billed with other surgical procedures same session |
| Anesthesia | General anesthesia is standard; separately billable under the anesthesia provider’s claim — CPT 00350 (head and neck) or the anesthesia code most accurately reflecting the surgical site and patient risk |
Bilateral Billing Rules
30160 has a bilateral indicator of 0, meaning this code is not subject to bilateral payment reduction rules. The external nose is a single midline structure — there is no bilateral equivalent for total rhinectomy, and modifier -50 is never appropriate for this code. When co-surgery (−62) is applicable (e.g., a head and neck oncologic surgeon performs the resection while a plastic and reconstructive surgeon simultaneously performs microvascular free flap reconstruction), each surgeon bills their respective procedure code with modifier -62 appended — not two units of 30160. Payer requirements for co-surgery documentation include: a single operative report documenting both surgeons’ roles, or two separate operative notes cross-referencing the other surgeon’s contribution.
🏷️ Modifier Reference
| Modifier | Name | When to Apply |
|---|---|---|
| -22 | Increased Procedural Services | When total rhinectomy required substantially greater work than typical — e.g., prior radiation field, recurrent disease with scarred tissue planes, concurrent extensive skull base involvement; operative note must document specific complexity factors; attach a cover letter to the claim |
| -25 | Significant, Separately Identifiable E/M | Applied to the E/M code — not 30160 — when a separate, medically necessary evaluation is performed same date beyond the pre-procedure assessment; uncommon on the day of a major surgical procedure |
| -24 | Unrelated E/M During Postoperative Period | Applied to the E/M code when patient returns within the 90-day global window for a condition unrelated to the rhinectomy (e.g., hypertensive crisis, new diagnosis); document the unrelated nature explicitly |
| -51 | Multiple Procedures | When 30160 is performed alongside other separately reportable surgical procedures at the same session (e.g., concurrent neck dissection, ethmoidectomy); apply to the lower-valued code |
| -54 | Surgical Care Only | When the resecting surgeon performs the rhinectomy but the post-operative care (wound management, reconstruction follow-up) is transferred to a different provider; the 90-day global must be split appropriately |
| -55 | Postoperative Management Only | Provider accepting post-operative care of the rhinectomy patient during the 90-day global period after initial surgery was performed by a different surgeon (e.g., reconstructive surgeon assuming post-op care) |
| -56 | Preoperative Management Only | Provider performing only the pre-operative evaluation while the surgery and post-op care are managed by the operating surgeon |
| -58 | Staged or Related Procedure | Staged reconstructive procedure(s) during the 90-day global period — e.g., planned delayed nasal reconstruction with forehead flap, free flap, or prosthetic fitting after initial rhinectomy; opens a new global period for the reconstruction code |
| -59 | Distinct Procedural Service | When payers inappropriately bundle 30160 with another procedure performed at a genuinely distinct anatomic site same session |
| -XS | Separate Structure | Preferred over -59 when distinct anatomy drives the separation — e.g., 30160 reported alongside a sinus surgery code at a distinct sinonasal site |
| -62 | Two Surgeons (Co-Surgery) | When two surgeons of distinct specialties each perform distinct, non-overlapping portions of the procedure simultaneously (e.g., oncologic resection + microvascular reconstruction); both surgeons append -62 to their respective procedure codes; each surgeon documents their own operative note |
| -76 | Repeat Procedure by Same Physician | Repeat procedure by the original surgeon during or after the 90-day global period — document medical necessity for repeat intervention |
| -78 | Unplanned Return to OR | Unplanned return for a complication during the 90-day global period — e.g., post-operative hematoma, wound dehiscence requiring OR-level intervention |
| -79 | Unrelated Procedure During Postoperative Period | Unrelated surgical procedure performed during the 90-day global window |
| -80 | Assistant Surgeon | When an assistant surgeon participated; document medical necessity in the operative note |
| -82 | Assistant Surgeon (Qualified Resident Not Available) | Teaching hospital setting where a qualified resident is not available to assist |
🩺 Common ICD-10-CM Pairings
Malignant Neoplasm — Nose (Primary Diagnoses)
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| C30.0 | Malignant neoplasm of nasal cavity | ✅ HCC | Use when the primary tumor originates from the nasal cavity mucosa (internal nose); this code is appropriate when total rhinectomy is driven by tumor extension from the nasal cavity to the external nose — confirm primary site with pathology and operative documentation |
| C44.311 | Basal cell carcinoma of skin of nose | ✅ HCC | Most common indication for total rhinectomy — advanced or centrally recurrent BCC requiring complete nasal extirpation; code as the principal diagnosis when BCC is the primary indication; document tumor size, prior treatment history, and margin status |
| C44.321 | Squamous cell carcinoma of skin of nose | ✅ HCC | Second most common malignant indication; SCC of the nasal skin with deep invasion or large size requiring total rhinectomy; confirm tumor origin (skin vs. nasal cavity mucosa) with pathology to differentiate from C30.0 |
| C44.391 | Other specified malignant neoplasm of skin of nose | ✅ HCC | Use for rare malignant skin tumors of the nose not classified as BCC or SCC (e.g., sebaceous carcinoma, Merkel cell carcinoma of the nasal skin); confirm histologic type with pathology report |
| C43.31 | Malignant melanoma of nose | ✅ HCC | Cutaneous melanoma of the nasal skin requiring total rhinectomy for adequate margins; note distinction from mucosal melanoma (C30.0) — confirm primary site |
| D03.39 | Melanoma in situ of other parts of face | ❌ No | Melanoma in situ of the nose — pre-invasive; total rhinectomy for melanoma in situ is uncommon but may be appropriate for very extensive lesions; query pathology for in situ vs. invasive classification before assigning |
Recurrent or Secondary Malignancy
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| C44.311 | Basal cell carcinoma of skin of nose — recurrent | ✅ HCC | ICD-10-CM does not have a specific “recurrent” character for C44.311; document recurrence in the clinical record; the recurrent nature supports medical necessity for total (vs. partial) rhinectomy and should be referenced in the operative and pre-authorization documentation |
| Z85.828 | Personal history of other malignant neoplasm of skin | ❌ No | Report as secondary diagnosis when the patient has a prior history of nasal skin malignancy that contributes to the decision for total rhinectomy; supports medical necessity narrative for extent of resection |
| Z79.899 | Other long-term (current) drug therapy | ❌ No | Report when patient is on immunosuppressive therapy (e.g., post-transplant) that contributed to aggressive or extensive nasal malignancy — supports medical necessity and complexity |
Adjunct / Secondary Diagnoses
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| Z12.11 | Encounter for screening for malignant neoplasm of colon | ❌ No | Not applicable here — this is a placeholder; use appropriate Z-codes for staging workup encounters (e.g., Z01.818 for pre-op evaluation) as secondary codes |
| Z01.812 | Encounter for preprocedural laboratory examination | ❌ No | Use for pre-operative laboratory workup encounters prior to total rhinectomy when that is the primary purpose of the visit |
| Z51.12 | Encounter for antineoplastic immunotherapy | ❌ No | Report when the patient is receiving concurrent immunotherapy for nasal malignancy — supports clinical complexity and medical necessity documentation |
Coding Specificity Reminder
The most critical specificity axis for CPT 30160 ICD-10-CM pairings is histologic type — BCC (C44.311), SCC (C44.321), melanoma (C43.31), and other specified (C44.391) are distinct codes with distinct HCC and quality reporting implications. Defaulting to an unspecified malignant neoplasm code without reviewing the pathology report is a compliance gap. Additionally, the anatomic origin of the tumor — nasal cavity mucosa (C30.0) vs. nasal skin (C44.3xx) — must be confirmed from pathology to select the correct primary code. ICD-10-CM specificity requirements are not optional — review the pathology report, confirm histology, and query the provider when origin or histologic type is ambiguous before coding.
🏥 MS-DRG Considerations (Inpatient)
Inpatient Coding Reminder
CPT 30160 is performed primarily in the outpatient hospital or ASC setting for oncologic total rhinectomy. Inpatient admission is expected when the procedure is part of a more extensive craniofacial oncologic resection, when the patient has significant comorbidities requiring post-operative monitoring, or when concurrent procedures (neck dissection, orbital exenteration, skull base surgery) add complexity warranting inpatient status. In the inpatient facility, the ICD-10-PCS code is required — not the CPT code. When total rhinectomy drives an inpatient admission, the procedure maps to MDC 03 (Diseases and Disorders of the Ear, Nose, Mouth, and Throat), grouping to DRG 133 / 134 / 135 (Other Ear, Nose, Mouth, and Throat O.R. Procedure with MCC / with CC / without CC/MCC). The presence of documented malignancy with metastatic disease, concurrent organ dysfunction, or major surgical complication as an MCC will upgrade the DRG to the highest-weight tier. CDI querying for malignancy staging, metastatic disease, and procedure-specific complications is essential for accurate DRG capture.
🔧 ICD-10-PCS Equivalents (Inpatient Facility Coding)
Note
Inpatient PCS coding for 30160 is encountered in craniofacial oncologic admissions. The PCS root operation is Resection (T) — defined as complete excision of a body part without replacement — which correctly maps to total rhinectomy. This distinguishes it from Excision (B), which would apply only to partial removal. The body system for the external nose in PCS is the Ear, Nose, Sinus (9) system, with specific body part characters for nasal bone and nasal structures. Because total rhinectomy involves multiple distinct body parts (nasal bone, nasal cartilage/septum, nasal skin/soft tissue), multiple PCS codes may be required to fully capture the procedure — assign one code per distinct body part resected per PCS Official Guideline B3.2a.
| PCS Code | Full Description | Applicable Component |
|---|---|---|
09TK0ZZ | Resection of Nasal Bone, Open Approach, No Device, No Qualifier | Resection of the bony nasal pyramid (nasal bones) — open approach standard for total rhinectomy |
09TM0ZZ | Resection of Nasal Septum, Open Approach, No Device, No Qualifier | Resection of the cartilaginous nasal septum included in total rhinectomy |
09TL0ZZ | Resection of Nasal Turbinate, Open Approach, No Device, No Qualifier | Only if nasal turbinates are included in the resection (rare in standard total rhinectomy unless nasal cavity is involved) |
0JB10ZZ | Excision of Face Subcutaneous Tissue and Fascia, Open Approach, No Device, No Qualifier | Excision of nasal soft tissue envelope (skin, subcutaneous tissue — PCS body part “Face” covers the nasal skin surface) |
PCS Character Analysis — 09TK0ZZ
| Position | Character | Value | Definition |
|---|---|---|---|
| 1 | Section | 0 | Medical and Surgical |
| 2 | Body System | 9 | Ear, Nose, Sinus |
| 3 | Root Operation | T | Resection (complete excision of a body part without replacement) |
| 4 | Body Part | K | Nasal Bone |
| 5 | Approach | 0 | Open (cutting through the skin or mucous membrane and other body layers to expose the site) |
| 6 | Device | Z | No Device |
| 7 | Qualifier | Z | No Qualifier |
PCS Root Operation: Resection (T) vs. Excision (B)
- Use Resection (T) when the entire nasal bone, nasal septum, or other defined body part is removed — this correctly captures total rhinectomy at the level of each complete anatomic body part
- Use Excision (B) only when a portion of the body part is removed (partial excision) — this would map to 30150 (partial rhinectomy) at the CPT level; do not use Excision for total rhinectomy coding
- Because total rhinectomy involves multiple distinct body parts (nasal bone, septum, soft tissue envelope), assign separate PCS codes for each distinct body part resected — PCS Guideline B3.2a prohibits combining multiple body parts into a single code when distinct body part characters exist for each
📝 Coding Examples
Example 1 — Outpatient Hospital: Total Rhinectomy for Advanced BCC of the Nose
Clinical Scenario: A 74-year-old male presents to the head and neck surgery clinic with a 5-year history of progressively enlarging nasal tumor. Biopsy confirms infiltrative basal cell carcinoma of the nasal skin involving all nasal subunits — bilateral alae, nasal tip, dorsum, and columella with deep invasion into underlying cartilage. Mohs surgery had been attempted twice at outside institutions without achieving clear margins. Pre-operative CT confirms tumor involvement of the upper and lower lateral cartilages bilaterally, nasal bones, and anterior cartilaginous septum. The patient is taken to the outpatient OR under general anesthesia. The operative note documents: “Total rhinectomy performed; incisions carried circumferentially around the nasal base; entire nasal skin envelope, bilateral nasal bones, all nasal cartilages, and columella excised en bloc; frozen sections confirm margins clear; wound covered with bolster dressing; nasal prosthetic rehabilitation to be planned as staged reconstruction.” No separate E/M was performed on the operative date.
| Field | Code | Rationale |
|---|---|---|
| CPT | 30160 | Total rhinectomy — operative note explicitly confirms entire external nasal structure removed en bloc; the word “total” and the enumerated components (all bones, all cartilages, complete skin envelope) satisfy the code descriptor requirement |
| PDx | C44.311 | Basal cell carcinoma of skin of nose — histologically confirmed by biopsy; primary indication for total rhinectomy; most specific code for BCC at the nasal skin site |
| SDx | Z85.828 | Personal history of prior skin malignancy treatment (prior Mohs attempts) — documents recurrence history supporting medical necessity for total vs. partial resection |
Note
No modifier -25 is applicable on the day of surgery — the pre-operative evaluation is bundled into the 90-day global for 30160. If the patient undergoes planned nasal prosthetic fitting or delayed free flap reconstruction during the 90-day global period, those services are reported separately with modifier -58 (staged/related procedure), which opens a new global period for the reconstruction. The bolster dressing and wound care during the 90-day global are bundled.
Example 2 — Outpatient Hospital: Total Rhinectomy + Concurrent Neck Dissection for SCC with Nodal Metastasis
Clinical Scenario: A 68-year-old female presents with total nasal squamous cell carcinoma confirmed on punch biopsy, with palpable right level IB cervical lymphadenopathy. PET-CT confirms the nasal primary with a single right-sided cervical lymph node metastasis at level IB. She is taken to the outpatient OR under general anesthesia. The operative note documents two distinct procedures performed sequentially by the same surgeon: (1) total rhinectomy with en bloc removal of the entire external nasal unit achieving clear frozen section margins, and (2) right selective neck dissection (levels I-III) for regional nodal clearance. Immediately following resection, the plastic surgery co-surgeon performs a pedicled paramedian forehead flap for nasal reconstruction simultaneously staged to begin at this same session.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 30160--62 | Total rhinectomy — primary oncologic procedure; -62 indicates co-surgery with the plastic surgeon performing simultaneous reconstruction; each surgeon bills their own component |
| CPT 2 | 38720--51 | Cervical lymphadenectomy (radical neck dissection, complete) or 38724 (cervical lymphadenectomy, modified radical) — confirm with operative note which dissection level(s) were performed; -51 = multiple procedures; apply to the lower-valued code between 30160 and the neck dissection |
| CPT 3 | 15731--62 | Forehead flap pedicle — billed by the reconstructive surgeon with -62 co-surgery modifier; verify the exact reconstruction code matches the documented flap type |
| PDx | C44.321 | Squamous cell carcinoma of skin of nose — histologically confirmed; primary reason for operative encounter |
| SDx | C77.0 | Secondary and unspecified malignant neoplasm of lymph nodes of head, face, and neck — nodal metastasis confirmed on PET-CT and surgical pathology; supports neck dissection medical necessity |
Warning
When co-surgery -62 is used, both surgeons must document their distinct, non-overlapping contributions in the operative record — either as a single joint operative note explicitly identifying each surgeon’s role or as two separate operative notes cross-referencing the other. Payers require proof that each surgeon’s service was medically necessary and could not have been performed by a single surgeon alone. Without this documentation, both -62 claims are at risk for denial or downpayment to an assistant surgeon (80%) rate instead of the full co-surgery (62.5% each) rate.
Example 3 — Outpatient Hospital: Total Rhinectomy for Mucosal Melanoma with Staged Reconstruction
Clinical Scenario: A 59-year-old female presents with sinonasal mucosal melanoma (pathology confirmed) originating in the nasal cavity with anterior extension through the nasal vestibule and skin of the external nose. MRI confirms tumor invasion through the anterior cartilaginous septum and both nasal alae. The surgical plan calls for total rhinectomy as part of the oncologic resection, with nasal reconstruction deferred by at least 6 weeks pending clear final margins and adjuvant therapy decisions. The patient is taken to the outpatient OR. Operative note documents: “Total rhinectomy performed; entire external nasal unit including nasal bones, all cartilaginous framework, nasal skin, and anterior cartilaginous septum excised; anterior nasal cavity defect controlled; margins submitted for permanent pathology.” Six weeks later (within the 90-day global), the patient returns for planned free anterolateral thigh (ALT) flap nasal reconstruction.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 (Session 1) | 30160 | Total rhinectomy — operative note confirms complete removal of entire external nasal unit |
| CPT 2 (Session 2 — Week 6) | 15758--58 | Free fasciocutaneous flap with microvascular anastomosis — ALT flap for nasal reconstruction; modifier -58 = staged/related procedure during 90-day global period of 30160; opens a new global period for the reconstruction |
| PDx | C30.0 | Malignant neoplasm of nasal cavity — mucosal melanoma originates from nasal cavity mucosa; this is the primary site code for sinonasal mucosal melanoma; confirm primary site documentation from pathology and operative report |
| SDx | C43.31 | Malignant melanoma of nose — external nose involvement documented; report as secondary code to capture the external nasal extension when both internal and external nose are involved |
Note
Global period reminder: The staged free flap reconstruction (Session 2) is billed with modifier -58, which signals a planned staged procedure related to the initial total rhinectomy. This modifier is critical — without it, the reconstruction claim will be automatically denied as being within the active 90-day global period of 30160. The -58 modifier opens a new 90-day global clock starting on the reconstruction date. Ensure the surgical plan for staged reconstruction is documented in the initial rhinectomy operative note (“nasal reconstruction deferred pending final pathology and adjuvant therapy — planned free flap at 6-8 weeks”).
⚠️ Common Coding Pitfalls
-
Upcoding partial rhinectomy to 30160 without documenting complete nasal removal: The most common audit finding for 30160 is an operative note that describes removal of “most” of the nose or multiple nasal subunits, but does not explicitly confirm total removal of the entire external nasal unit. If any component of the nasal framework (e.g., nasal bones, dorsal skin, or one alar cartilage) is preserved, 30150 (partial rhinectomy) is the correct code. The operative note must unambiguously state that the entire external nose was removed — enumerate the components excised. The financial difference between 30160 (wRVU 12.06) and 30150 (wRVU ~7.x) is substantial, and the code selection must be driven exclusively by the operative documentation.
-
Failing to use modifier -58 for staged reconstruction within the 90-day global period: Total rhinectomy is almost always followed by reconstruction — whether a forehead flap, free tissue transfer, or prosthetic rehabilitation — that occurs within weeks of the initial procedure and thus falls within the 90-day global window. Billing the reconstruction codes without modifier -58** will result in automatic claim denial. Coders must track the rhinectomy procedure date, identify any reconstruction claims that fall within 90 days, and ensure -58 is applied. Failure to do so is the single most common post-payment recoupment finding for this code.
-
Incorrect use of co-surgery modifier -62 without adequate documentation: When total rhinectomy is performed by an oncologic surgeon with simultaneous reconstruction by a plastic surgeon, modifier -62 is appropriate — but only if both surgeons document their distinct, non-overlapping roles. Applying -62 when one surgeon performs the entire procedure (resection and reconstruction sequentially without a true co-surgery arrangement) constitutes overcoding and is a significant fraud/abuse risk. The operative record must show two surgeons present simultaneously with distinct documented contributions.
-
Using C44.311 (BCC of skin of nose) when the primary tumor originates from nasal mucosa: Basal cell carcinoma does not arise from nasal cavity mucosa — it arises from skin only. When the pathology report confirms a mucosal origin tumor (e.g., mucosal melanoma, adenocarcinoma, SCC of nasal mucosa), the correct primary diagnosis code is C30.0 (malignant neoplasm of nasal cavity), not C44.3xx. Mixing these two code families based on the external nose being the operative site — rather than the tumor’s tissue of origin — is a coding error that misrepresents the clinical picture and may trigger medical necessity queries from payers.
-
Separately billing wound dressing changes or post-op visits as E/M services during the 90-day global: Total rhinectomy’s 90-day global bundles all routine post-operative care. Wound dressing changes, suture removal, post-operative pain management, and healing assessments are included — not separately billable. Coders who allow routine post-op visits to be billed as E/M services without a modifier during the 90-day window are generating overpayments. Ensure billing staff have a workflow to identify and hold routine post-operative visits for this procedure family during the global window.
-
Defaulting to unspecified malignant neoplasm of nose without reviewing the pathology report: C44.301 (unspecified malignant neoplasm of skin of nose) should never be used when the pathology report specifies BCC, SCC, or melanoma — all of which have distinct, more specific codes (C44.311, C44.321, C43.31). Reviewing the pathology report before coding is not optional for oncologic procedures — it is the standard of care for accurate ICD-10-CM assignment and correct HCC capture, which directly impacts risk adjustment, quality metrics, and — in the inpatient setting — DRG weight.
📎 Sources
AMA CPT 2025 Professional Edition · CMS 2025 Medicare Physician Fee Schedule Final Rule (CMS-1807-F) · CMS RVU25A Relative Value Files · NCCI Policy Manual Chapter 5 (Respiratory System), CMS 2024-2025 · ICD-10-CM Official Guidelines for Coding and Reporting FY2025 · ICD-10-PCS Official Guidelines for Coding and Reporting FY2025 · AAO-HNS CPT for ENT: Turbinectomy Guidance and Rhinectomy Code Differentiation (American Academy of Otolaryngology - Head and Neck Surgery, 2025) · AAPC Otolaryngology Coding Alert — “Bilateral Turbinate Resection” and Adjacent Rhinectomy Code Reference (AAPC, 2000; updated guidance 2024) · PayerPrice — CPT 30160 Fee Schedule and Payer Reimbursement Reference (September 2025) · Noridian Medicare JE Part B — 2025 MPFS Indicator List and Descriptors (Bilateral Indicator Reference) · FindACode — CPT 30160 Code Reference (February 2026)